Long COVID Can Damage Joints and Bones

Long COVID Can Damage Joints and Bones

Post-acute sequelae of SARS-CoV-2 infection (PASC) continues to affect coronavirus disease 2019 (COVID-19) patients for weeks and even months after disease resolution. Severe COVID precipitates systemic inflammation and blood clotting abnormalities, hampering bone blood supply – leading to avascular necrosis (AVN).

AVN is a condition in which bone tissue dies due to a lack of blood supply. COVID-19 may lead to AVN through systemic inflammation and blood clotting abnormalities that disrupt blood supply to the bone. AVN treatment depends on the disease stage and location of the affected bone, the patient's age, and overall health. Early diagnosis and treatment can improve outcomes and help prevent long-term joint damage.

According to Dr. Vaibhav Bagaria, Director of Orthopedics at Sir H N Reliance Foundation Hospital and Research Centre in Mumbai, the exact way in which COVID-19 may cause AVN remains enigmatic. Likely, it could be related to the systemic inflammation and blood clotting abnormalities common in severe COVID-19 cases. These physiological changes can disrupt blood supply to the bones. 

Long COVID (PASC) is known to cause joint and bone pains, but the reason behind the persistent symptoms and the deleterious effects on joint health are yet to be ascertained. Some studies suggest that up to 50% of people with long COVID experience joint pain or arthritis-like symptoms. Prolonged physiological inflammatory response has been implicated in the damage caused to the joints and surrounding tissues. Further research is needed to fully understand the effects of long COVID on joint health. Those experiencing joint pain or other musculoskeletal symptoms should seek medical evaluation and treatment to prevent potential long-term joint damage.

user
IJCP Editorial Team

Comprising seasoned professionals and experts from the medical field, the IJCP editorial team is dedicated to delivering timely and accurate content and thriving to provide attention-grabbing information for the readers. What sets them apart are their diverse expertise, spanning academia, research, and clinical practice, and their dedication to upholding the highest standards of quality and integrity. With a wealth of experience and a commitment to excellence, the IJCP editorial team strives to provide valuable perspectives, the latest trends, and in-depth analyses across various medical domains, all in a way that keeps you interested and engaged.

 More FAQs by IJCP Editorial Team

Logo

Medtalks is India's fastest growing Healthcare Learning and Patient Education Platform designed and developed to help doctors and other medical professionals to cater educational and training needs and to discover, discuss and learn the latest and best practices across 100+ medical specialties. Also find India Healthcare Latest Health News & Updates on the India Healthcare at Medtalks